DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Afamelanotide is an investigational drug.
There have been 10 clinical trials for Afamelanotide. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2007.
The most common disease conditions in clinical trials are Protoporphyria, Erythropoietic, Vitiligo, and Keratosis, Actinic. The leading clinical trial sponsors are Clinuvel Pharmaceuticals Limited and [disabled in preview].
Recent Clinical Trials for Afamelanotide
|Phase III Confirmatory Study in Erythropoietic Protoporphyria||Clinuvel Pharmaceuticals Limited||Phase 3|
|Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo||Clinuvel Pharmaceuticals Limited||Phase 2|
|Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)||Clinuvel Pharmaceuticals Limited||Phase 1|